| Malignant Uterine Corpus Neoplasm studied in …STUDIED_INderived200 of 1,571show all (up to 200) |
|---|
| → studied in | NCT02465060Phase 2 · active not recruiting Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) · condition mapped ONTOLOGY_EXACT · 1,571 trials mapped (536 active) | — | — | Malignant Uterine Corpus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03348631Phase 2 · active not recruiting Tazemetostat in Treating Patients With Recurrent Ovarian or Endometrial Cancer · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Uterine Corpus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05051722recruiting Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05256225Phase 3 · recruiting Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma · condition mapped ONTOLOGY_EXACT · 1,571 trials mapped (536 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05564377Phase 2 · recruiting Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06524583Phase 2 · recruiting Interest of Post-operative Chemotherapy in Patients With Localised Uterine Leiomyosarcoma Suspected of Having a High Risk of Recurrence Based on a Biological Test Performed on the Tumour · condition mapped ALIAS · 1,571 trials mapped (536 active) | — | — | Uterine Corpus Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07061977Phase 3 · recruiting Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Cervical Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07198074Phase 3 · recruiting Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07705035Phase 1 · recruiting DBC-664 in Adult Patients With Solid Tumors · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04789694Phase 3 · recruiting Prehabilitation in Gynaecological Cancer Patients · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05112601Phase 2 · recruiting Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05867251Phase 1/Phase 2 · recruiting Study of AVZO-021 in Patients With Advanced Solid Tumors · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06586957Phase 1 · recruiting A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07078838Phase 2 · not yet recruiting Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1 Endometrial Cancer · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07578649Phase 3 · not yet recruiting Symbiotic-GYN-18: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Advanced or Recurrent MMR-proficient Endometrial Cancer · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03564340Phase 1/Phase 2 · recruiting Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03643510Phase 2 · completed Evaluating Cancer Response to Treatment With Abemaciclib and Fulvestrant in Women With Recurrent Endometrial Cancer · condition mapped ALIAS · 1,571 trials mapped (536 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04945187NA · completed Patient-Reported Outcomes Among Women Wtih Gynecological Cancer (The CONNECT Study) · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06172478Phase 2 · recruiting A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06218914Phase 1 · recruiting Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07124000recruiting DESTINY-PANTUMOUR04 · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07270666NA · recruiting ctDNA Testing to Inform Standard-of-Care Treatment Decisions in People With Endometrial Cancer · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07508358Phase 1 · not yet recruiting Vaginal Sildenafil for Primary Dysmenorrhea · condition mapped ALIAS · 1,571 trials mapped (536 active) | — | — | Uterine Corpus Leiomyoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04590326Phase 1/Phase 2 · recruiting A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05640999Phase 2 · recruiting Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07594015Phase 2 · recruiting Pembrolizumab and Lenvatinib in Mismatch Repair Proficient Recurrent Endometrial Cancer After Progression on or Following First-Line Immunotherapy Maintenance · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07838207recruiting Prognosis and Therapeutic Implications in Molecular High-Risk Non-Myoinvasive Endometrial Cancer · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04044859Phase 1 · active not recruiting ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS) · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04145518Phase 4 · completed Mechanistic Characterization of Uterine Pain · condition mapped ALIAS · 1,571 trials mapped (536 active) | — | — | Uterine Corpus Leiomyoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05489211Phase 2 · recruiting Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03) · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07262619Phase 1/Phase 2 · recruiting EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04644068Phase 1/Phase 2 · active not recruiting Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05983432Phase 1 · recruiting Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06038032NA · recruiting ImpRoving hEalth behaviourS for LIfe After ENdometrial CancEr Trial · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06925724Phase 2 · recruiting A Study of Ivonescimab in People With Endometrial and Cervical Cancers · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07831902Phase 3 · recruiting Refining Adjuvant Treatment IN Endometrial Cancer Based On Molecular Features (RAINBO) - NSMP-ORANGE Trial: Comparing Radiotherapy With Oral Progestin Tablets vs. the Current Standard Care, Radiotherapy and Chemotherapy, in Patients With NSMP Endometrial Cancer · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07832227Phase 2 · not yet recruiting Imlunestrant/Abemaciclib/Selinexor in Ovarian and Endometrial · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04152499Phase 1/Phase 2 · active not recruiting Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies (KL264-01) · condition mapped ONTOLOGY_EXACT · 1,571 trials mapped (536 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05758688Phase 2 · recruiting PROton Therapy for Post Surgical Treatment of GYNecologic Cancer · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06340568Phase 3 · recruiting A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06952504Phase 3 · recruiting A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29) · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07109726Phase 1/Phase 2 · recruiting A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04604613active not recruiting Prediction of Recurrence Among Low Risk Endometrial Cancer Patients · condition mapped ONTOLOGY_EXACT · 1,571 trials mapped (536 active) | — | — | FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05677048NA · active not recruiting Feasibility Study: IGNITE-TX (Identifying Individuals for Genetic Testing & Treatment) Intervention · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06366347Phase 2 · recruiting ALPINE: Maintenance Letrozole/Abemaciclib · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06409052recruiting Endometrial Cancer, Risk Factors and Prevention Strategies: Perspectives of Patients and At-Risk Women · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07116213NA · recruiting Clinical Research on Moderately Hypofractionated Adaptive Postoperative Radiotherapy for High-Risk Endometrial Cancer · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07584161NA · recruiting MH-ART vs CF-IMRT in Postoperative Cervical/Endometrial Cancer · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04073706Phase 3 · recruiting Sentinel Node Biopsy in Endometrial Cancer · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04585750Phase 1/Phase 2 · recruiting The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE) · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07341737Phase 1/Phase 2 · recruiting SL-28 for Advanced Solid Tumours · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07820358Phase 2 · not yet recruiting Semaglutide, Weight Loss, and LNG-IUD for Conservative Treatment of Endometrial Atypical Hyperplasia and Grade 1 Endometrial Cancer · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00791635active not recruiting Longitudinal Evaluation of Women Undergoing Pelvic Surgery for the Treatment of Gynecologic Cancer · condition mapped ONTOLOGY_EXACT · 1,571 trials mapped (536 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04723095recruiting Establishing a Tumor Registry for Patients With Neuroendocrine Carcinoma of the Cervix · condition mapped ONTOLOGY_EXACT · 1,571 trials mapped (536 active) | — | — | Cervical Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05059444recruiting ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation · condition mapped ONTOLOGY_EXACT · 1,571 trials mapped (536 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05634499Phase 2 · completed A Study of Giredestrant in Participants With Grade 1 Endometrial Cancer · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05799274Phase 1 · active not recruiting Safety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Cancer or Other Solid Tumors · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05858736Phase 1 · completed Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05123482Phase 1/Phase 2 · recruiting A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05979493Phase 4 · recruiting QL Block in Laparoscopic Myomectomy · condition mapped ALIAS · 1,571 trials mapped (536 active) | — | — | Uterine Corpus Leiomyoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07065552early Phase 1 · recruiting Tirzepatide in Obesity-Driven Endometrial Cancer · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07815873NA · not yet recruiting Gut Microbiome in Patients With Lung and Melanoma Cancer and Intestinal Microbiota in Gynecologic Cancers · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02397083Phase 2 · active not recruiting Levonorgestrel-Releasing Intrauterine System With or Without Everolimus in Treating Patients With Atypical Hyperplasia or Stage IA Grade 1 Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 1,571 trials mapped (536 active) | — | — | FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04683653Phase 1/Phase 2 · suspended Study of Pelvic Hypofractionated Radiotherapy in Endometrial Cancer · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06293898Phase 1 · recruiting Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07812636early Phase 1 · not yet recruiting Tirzepatide and Levonorgestrel IUD Therapy for EIN and Early-Stage Endometrial Cancer · condition mapped ALIAS · 1,571 trials mapped (536 active) | — | — | FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07814248Phase 1 · not yet recruiting A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00977574Phase 2 · active not recruiting Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Uterine Corpus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03367741Phase 2 · active not recruiting Cabozantinib S-malate and Nivolumab in Treating Patients With Advanced, Recurrent, or Metastatic Endometrial Cancer · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03651206Phase 2/Phase 3 · recruiting Recurrent Ovarian CarcinoSarcoma Anti-pd-1 Niraparib · condition mapped ALIAS · 1,571 trials mapped (536 active) | — | — | Uterine Corpus Carcinosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07166094Phase 3 · recruiting Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02257528Phase 2 · active not recruiting Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer · condition mapped ONTOLOGY_EXACT · 1,571 trials mapped (536 active) | — | — | Cervical Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07041606recruiting An Observational Study of Molecular profIling of Advanced and aggRessive ENdometrial Cancer and 1-st Line Treatment Approaches in Russian Federation · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07807345Phase 1 · not yet recruiting Phase 1 Study of STRO-006 in Adults With Refractory Solid Tumors That Are Recurrent or Metastatic · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07808164recruiting ENPP1/cGAS (EG) and FAP Expression Profiles in Solid Tumors: An Immunohistochemical Study in a Vietnamese Cohort · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01366144Phase 1 · active not recruiting Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction · condition mapped ONTOLOGY_EXACT · 1,571 trials mapped (536 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02208375Phase 1 · active not recruiting mTORC1/2 Inhibitor AZD2014 or the Oral AKT Inhibitor AZD5363 for Recurrent Endometrial and Ovarian · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Uterine Corpus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04704661Phase 1 · active not recruiting Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05139368NA · active not recruiting Hypofractionated Radiotherapy for the Treatment of Cervical or Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 1,571 trials mapped (536 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05950464Phase 1 · recruiting Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06515613Phase 1 · recruiting A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06989112Phase 3 · recruiting DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07194551NA · recruiting Assessing Uterine Cancer Risk in Lynch Syndrome Carriers Using Vaginal Self-sampling and a Health Questionnaire · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07755436Phase 1 · recruiting Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer. · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05334069recruiting Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Uterine Corpus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06995833recruiting Durvalumab With or Without Olaparib in Patients With Endometrial Cancers Regulatory Post Marketing Surveillance · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07216105Phase 1 · recruiting FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 1,571 trials mapped (536 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04839614NA · recruiting Concurrent Laparoscopic Hysterectomy and Weight Loss Surgery in Obese Patients With Endometrial Carcinoma or Endometrial Intraepithelial Neoplasia · condition mapped ONTOLOGY_EXACT · 1,571 trials mapped (536 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07662824NA · recruiting Flyte Device for Improving Urinary Incontinence Among Endometrial and Cervical Cancer Survivors Who Have Undergone Radiation Therapy · condition mapped ONTOLOGY_EXACT · 1,571 trials mapped (536 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02142803Phase 1 · active not recruiting TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Uterine Corpus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03660826Phase 2 · active not recruiting Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib Alone · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06132958Phase 3 · active not recruiting Sacituzumab Tirumotecan (MK-2870) in Post Platinum and Post Immunotherapy Endometrial Cancer (MK-2870-005) · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07793318Phase 2 · not yet recruiting TR115 in ARID1A-Mutated Advanced Solid Tumors · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05611931Phase 3 · active not recruiting Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06014580completed Molecular and Epidemiological Characteristics of Endometrial Cancer in Brazil · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07227168Phase 1 · recruiting A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07544680recruiting Endometrial Cancer Vaginal Fluid Specimen Collection Study · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04329494Phase 1 · recruiting PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Uterine Corpus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07349641Phase 2 · not yet recruiting A Study of Weight Loss Intervention With Tirzepatide and Progestin Intrauterine Device to Treat Endometrial Hyperplasia and Grade 1 Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 1,571 trials mapped (536 active) | — | — | FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07383506Phase 1 · recruiting A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04670445NA · completed Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced Cancer · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04851119Phase 1/Phase 2 · recruiting Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors · condition mapped ONTOLOGY_EXACT · 1,571 trials mapped (536 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06276491Phase 1 · recruiting Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07779109NA · recruiting Pelvic Ultra-Hypofractionated Adjuvant Radiotherapy for Endometrial Cancer (PURE-cohort) · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07781150Phase 2 · not yet recruiting Mazdutide Plus LNG-IUS for Fertility-Sparing Treatment of AEH or Early Endometrial Cancer · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02466971Phase 3 · active not recruiting Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers · condition mapped ONTOLOGY_EXACT · 1,571 trials mapped (536 active) | — | — | Cervical Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04147494early Phase 1 · active not recruiting Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues · condition mapped ALIAS · 1,571 trials mapped (536 active) | — | — | Malignant Uterine Corpus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05548296Phase 2 · recruiting A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05797168Phase 1/Phase 2 · recruiting Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06774963Phase 1 · recruiting A Phase 1 Study of LNCB74 in Advanced Solid Tumors · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07623369Phase 1 · recruiting A First-in-Human Study of HH160 in Participants With Advanced or Metastatic Solid Tumors · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07780019active not recruiting Microwave Ablation of Uterine Fibroids · condition mapped ALIAS · 1,571 trials mapped (536 active) | — | — | Uterine Corpus Leiomyoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04569773active not recruiting Choosing Ovarian Preservation or Removal Before Surgery for Endometrial Cancer · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05269381Phase 1/Phase 2 · recruiting Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Uterine Corpus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05364008Phase 3 · active not recruiting FRIEND: Fibroids and Unexplained Infertility Treatment With Epigallocatechin Gallate; A Natural CompounD in Green Tea · condition mapped ALIAS · 1,571 trials mapped (536 active) | — | — | Uterine Corpus Leiomyoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06339827NA · completed ASk Questions in GYnecologic Oncology (ASQ-GYO) · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06538337NA · recruiting Hypofractionated External Beam Radiotherapy With Adaptive Planning for Endometrial and Cervical Cancers · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07227077NA · recruiting Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04104776Phase 1/Phase 2 · recruiting A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04567771NA · recruiting Comparison of Proton or Intensity Modulated Radiation Therapy After Surgery for Endometrial or Cervical Cancer · condition mapped ONTOLOGY_EXACT · 1,571 trials mapped (536 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05827614Phase 1 · terminated Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene Amplifications · condition mapped ONTOLOGY_EXACT · 1,571 trials mapped (536 active) | — | — | High Grade Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07772076not yet recruiting Prospective Perioperative Clinical Registry for Women Undergoing Benign Gynecological Surgery · condition mapped ALIAS · 1,571 trials mapped (536 active) | — | — | Uterine Corpus Leiomyoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05162846NA · completed Michigan Genetic Hereditary Testing (MiGHT) · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07182149Phase 1 · recruiting A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07470853Phase 1 · recruiting A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors. · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05919264Phase 1/Phase 2 · recruiting FOG-001 in Locally Advanced or Metastatic Solid Tumors · condition mapped ONTOLOGY_EXACT · 1,571 trials mapped (536 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06792552Phase 1 · recruiting A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors · condition mapped ALIAS · 1,571 trials mapped (536 active) | — | — | Endometrial Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05231122Phase 2 · recruiting Pembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for the Treatment of Patients With Recurrent Ovarian Cancer · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Endometrial Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00514254active not recruiting Risk Factors for Endometrial Cancer in Black Women · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05572684Phase 1/Phase 2 · terminated A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants With Advanced Unresectable or Metastatic Solid Tumors · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06399757Phase 1/Phase 2 · active not recruiting A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06543576Phase 1/Phase 2 · recruiting External Beam Radiation Therapy and Brachytherapy With Chemotherapy and Immunotherapy for the Treatment of Stage IVB Cervical Cancer · condition mapped ONTOLOGY_EXACT · 1,571 trials mapped (536 active) | — | — | Cervical Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06840886Phase 1 · recruiting A Study of PHST001 in Advanced Solid Tumors · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07382583recruiting Development of a Shared Decision Tool to Facilitate Uptake of the Levonorgestrel-releasing Intrauterine System for the Primary Prevention of Endometrial Cancer · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06242470Phase 1 · recruiting A Study of MGC026 in Participants With Advanced Solid Tumors · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05046080recruiting Clinicopathologic and Ancillary Testing of Primary Clear Cell Carcinoma of the Cervix · condition mapped ONTOLOGY_EXACT · 1,571 trials mapped (536 active) | — | — | Human Papillomavirus-Independent Cervical Adenocarcinoma, Clear Cell-Type | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06549855NA · recruiting PD-1 Inhibitor Combined With Progesterone Treatment in FST for Patients With MMRd Endometrial Cancer · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07741968NA · recruiting A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer · condition mapped ONTOLOGY_EXACT · 1,571 trials mapped (536 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07754877NA · not yet recruiting Safety and Efficacy of Microwave Ablation Alone Versus Microwave Ablation Combined With Chemical Ablation in the Treatment of Uterine Fibroids: A Prospective, Multicenter Study · condition mapped ALIAS · 1,571 trials mapped (536 active) | — | — | Uterine Corpus Leiomyoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04291612recruiting Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07038369Phase 1 · active not recruiting A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07752875Phase 1/Phase 2 · not yet recruiting A Study of LG00313112 in Participants With Advanced Solid Malignancies Harboring a TP53 Y220C Mutation · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07716735Phase 1 · not yet recruiting Mercaptopurine for the Treatment of Hereditary Leiomyomatosis and Renal Cell Carcinoma (HLRCC), Uterine/Cutaneous Leiomyomas, and Kidney Cancer · condition mapped ONTOLOGY_EXACT · 1,571 trials mapped (536 active) | — | — | Uterine Corpus Leiomyoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07059884NA · recruiting Distance-Based Exercise to Preserve Function and Prevent Disability · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07281547Phase 4 · not yet recruiting Low Dose Aspirin to Lower Inflammation and Prevent Endometrial Cancer in Postmenopausal Women With Non-atrophic Endometrial Changes and Pain · condition mapped ONTOLOGY_EXACT · 1,571 trials mapped (536 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07444814Phase 1 · recruiting Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07746349NA · not yet recruiting Terlipressin vs Placebo to Reduce Bleeding in Fibroid Surgery · condition mapped ALIAS · 1,571 trials mapped (536 active) | — | — | Uterine Corpus Leiomyoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05554328Phase 2 · active not recruiting Testing the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted Treatment for RAS Pathway Mutant Recurrent or Persistent Ovarian and Endometrial Cancers, A ComboMATCH Treatment Trial · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05579366Phase 1/Phase 2 · recruiting Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001) · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07746024active not recruiting Advancing Risk Stratification in Endometrial Cancer · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05603910Phase 1 · recruiting Phase 1 Clinical Trial of Lenvatinib, Pembrolizumab and Hypofractionated Pelvic Radiation Therapy for pMMR Recurrent/Unresectable Endometrial Carcinoma · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06096688recruiting Discovering New Targets for Colorectal and Endometrial Cancer Risk Reduction · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02595879Phase 1 · active not recruiting Triapine With Chemotherapy and Radiation Therapy in Treating Patients With IB2-IVA Cervical or Vaginal Cancer · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Cervical Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03914612Phase 3 · active not recruiting Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 1,571 trials mapped (536 active) | — | — | Endometrial Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04491942Phase 1 · active not recruiting Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07259304active not recruiting Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Uterine Corpus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07419841Phase 1 · recruiting A Phase 1 Study of the Safety and Tolerability of CTX-10726 · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07738315Phase 2 · not yet recruiting Elemene Liposomes in Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 1,571 trials mapped (536 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07739745NA · not yet recruiting Development Of An Endometrial Cancer Educational Tool · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01797523Phase 2 · completed A Phase II, Single-Arm Study of RAD001 (Everolimus), Letrozole, and Metformin in Patients With Advanced or Recurrent Endometrial Carcinoma · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03526432Phase 2 · active not recruiting Phase II Study of Atezolizumab + Bevacizumab in Endometrial Cancer · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04657068Phase 1/Phase 2 · recruiting A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07285044Phase 2 · recruiting The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas · condition mapped ONTOLOGY_EXACT · 1,571 trials mapped (536 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07730970NA · recruiting Deep Neuromuscular Blockade and a Low-Residue Diet for the Surgical Field in vNOTES Hysterectomy · condition mapped ALIAS · 1,571 trials mapped (536 active) | — | — | Uterine Corpus Leiomyoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07737795Phase 2 · not yet recruiting Evaluating the Addition of OK-1 Weekly Paclitaxel in Patients With Endometrial Cancer · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03538665recruiting The DETECT Study: Discovery and Evaluation of Testing for Endometrial and Ovarian Cancer in Tampons · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06486441Phase 3 · active not recruiting Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer After Platinum-Based Chemotherapy and Immunotherapy (ASCENT-GYN-01/GOG-3104/ENGOT-en26) · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07044336Phase 3 · recruiting Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01) · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07200466NA · recruiting Individualised Endometrial Cancer Risk Stratification by Bayesian Prediction Model (ENDORISK), Optimizing Clinical Implementation · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02912572Phase 2 · active not recruiting Avelumab in Patients With MSS, MSI-H and POLE-mutated Recurrent or Persistent Endometrial Cancer and of Avelumab/Talazoparib and Avelumab/Axitinib in Patients With MSS Recurrent or Persistent Endometrial Cancer · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07022483Phase 3 · recruiting Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05538897Phase 1/Phase 2 · active not recruiting Testing the Addition of the AKT Inhibitor, Ipatasertib, to Treatment With the Hormonal Agent Megestrol Acetate for Recurrent or Metastatic Endometrial Cancers · condition mapped ONTOLOGY_EXACT · 1,571 trials mapped (536 active) | — | — | FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07725159NA · completed Comparison of Lee-Huang Point and Umbilical Entry for Laparoscopic Success in Endometrial Cancer Patients · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03586661Phase 1 · completed Niraparib and Copanlisib in Treating Patients With Recurrent Endometrial, Ovarian, Primary Peritoneal, or Fallopian Tube Cancer · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05180474Phase 1/Phase 2 · terminated GEN1047 for Solid Tumors - First in Human (FIH) Trial · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05714553Phase 1/Phase 2 · terminated NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours · condition mapped ONTOLOGY_EXACT · 1,571 trials mapped (536 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06974110Phase 1 · recruiting Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07723235NA · not yet recruiting Web-based Lifestyle Program, mHealth and EMA Intervention, to Improve Weight Loss in Rural Stage I-III Postmenopausal Breast and Endometrial Cancer Survivors, HERO-C Trial · condition mapped ONTOLOGY_EXACT · 1,571 trials mapped (536 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05208762Phase 1 · recruiting A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06143631Phase 4 · recruiting Prescription of Letrozole for Uterine Myoma · condition mapped ALIAS · 1,571 trials mapped (536 active) | — | — | Uterine Corpus Leiomyoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07524322Phase 1 · recruiting Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03120624Phase 1 · active not recruiting VSV-hIFNbeta-NIS With or Without Ruxolitinib Phosphate in Treating Stage IV or Recurrent Endometrial Cancer · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Uterine Corpus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03400826Phase 2 · active not recruiting Effects of Simvastatin on Uterine Leiomyoma Size · condition mapped ALIAS · 1,571 trials mapped (536 active) | — | — | Uterine Corpus Leiomyoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04092270Phase 1 · active not recruiting A Study Combining the Peposertib (M3814) Pill With Standard Chemotherapy in Patients With Ovarian Cancer With an Expansion in High Grade Serous Ovarian Cancer and Low Grade Serous Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 1,571 trials mapped (536 active) | — | — | Endometrial High Grade Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06476808Phase 1 · recruiting A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors. · condition mapped ALIAS · 1,571 trials mapped (536 active) | — | — | Endometrial Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07714070Phase 2 · not yet recruiting Orlistat Plus Progestin for Fertility-Sparing Treatment of Endometrial Cancer or Atypical Hyperplasia · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07715747Phase 1 · not yet recruiting A Phase I Study to Evaluate the Safety,Pharmacokinetics,Pharmacodynamics,and Efficacy of TJ037130 in Adult Participants With Advanced Solid Tumors · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04469764Phase 2 · recruiting Abemaciclib for the Treatment of Recurrent Ovarian or Endometrial Cancer · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04719273Phase 2 · completed Onapristone and Anastrozole for the Treatment of Refractory Hormone Receptor Positive Endometrial Cancer · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05078047Phase 3 · active not recruiting Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO · condition mapped ONTOLOGY_EXACT · 1,571 trials mapped (536 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07702799NA · recruiting Low-Residue Diet Versus Rectal Enema Before Laparoscopic Surgery for Endometrial Cancer · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04622670NA · active not recruiting Yoga Therapy During Chemotherapy and Radiation Treatment for the Improvement of Physical and Emotional Well-Being in Patients With Stage IB2-IIIB Cervical Cancer · condition mapped ONTOLOGY_EXACT · 1,571 trials mapped (536 active) | — | — | Cervical Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05092373Phase 1 · recruiting Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Uterine Corpus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06906341Phase 2 · recruiting Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07209449Phase 2 · recruiting A Study of Elacestrant Alone or in Combination With Abemaciclib in People With Endometrial Cancer · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06129604Phase 2 · active not recruiting Pilot Window of Opportunity Trial (POET) · condition mapped ONTOLOGY_EXACT · 1,571 trials mapped (536 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06533059Phase 1 · active not recruiting A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid Tumors · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07220512recruiting The Better, Harder, Faster, Stronger Study · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07352761NA · completed Bilateral Uterine Artery Occlusion During Laparoscopic Myomectomy · condition mapped ALIAS · 1,571 trials mapped (536 active) | — | — | Uterine Corpus Leiomyoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07622901NA · recruiting Fasting InTervention for Endometrial Cancer · condition mapped CURATED_BROADER · 1,571 trials mapped (536 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |